TP53 and acute myeloid leukemia: The wild-type (WT) TP53 (TP53wt) gene translation of normal p53 protein expression contributes significantly to therapeutic efficacy in AML, by enabling apoptosis of leukemic cells exposed to chemotherapy [1].